The system of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) may play a key role in atherogenesis of chronic kidney disease (CKD) patients by its impact on matrix accumulation.
Some studies have reported poor correlations between clinical measures of ankylosing spondylitis (AS) disease activity, such as the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) score, ...
Matrix metalloproteinases (MMPs) are proteolytic enzymes that play a central role in benign and malignant matrix remodelling (Kähäri and Saarialho-Kere, 1999; Nagase and Woessner, 1999). MMP-2 and MMP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback